NewsEvents

Your Yourlocation: Home > Efficacy of budesonide dermotorol combined with tiotropium bromide(136310-93-5) in the treatment of stable chronic obstructive pulmonary disease

To investigate the efficacy of budesonide dermotorol powder combined with tiotropium bromide(136310-93-5) in the treatment of stable chronic obstructive pulmonary disease. Methods: 72 patients with stable chronic obstructive pulmonary disease were randomly divided into study group and control group. The control group was treated with budesonide dermotam powder. The study group was treated with tiotropine Ammonia treatment, analysis of the two groups of patients with lung function, arterial blood gas analysis, St. George breathing questionnaire (SGRQ), the incidence of adverse reactions. Results: Compared with the control group, the pulmonary function, arterial blood gas index and SGRQ score of the study group were significantly improved, the difference between the two groups was statistically significant (P <0.05); the two groups of patients were not serious adverse reactions. Conclusion: The combination of budesonide dermatotil powder and tiotropium bromide(136310-93-5) in the treatment of stable chronic obstructive pulmonary disease is effective, which can improve the pulmonary function of patients. The clinical application value is significant.

Address:211#Zhengfeng Building,Huanbaokejiyuan, Gaoxinkaifaqu, Jinan,250100,China TEL:086-531-82375818 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved